Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

IRTC PEER ANALYSIS

iRhythm Technologies Inc — metric-by-metric comparison with peers and the industry median

IRTCiRhythm Technologies Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
IRTCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
IRTC-10.1%COH-56.7%4DX+1,679.6%PHIA+25.4%SHL-23.6%SN+5.4%
Year-to-Date (YTD)
IRTC-29.5%COH-50.3%4DX+10.9%PHIA+9.5%SHL-20.5%SN-6.4%
1-Year
Split-adjusted
IRTC-10.1%LIVN+83.4%HAE-0.3%ITGR-21.5%TMDX-43.2%AXGN+292.3%
Year-to-Date (YTD)
IRTC-29.5%LIVN+35.8%HAE-6.6%ITGR+17.2%TMDX-41.5%AXGN+36.2%

Key Metric Comparison

P/E

Lower is better
IRTC—COH24.274DX—PHIA24.46SHL18.72SN20.73Median 26.82

ROE

Higher is better
IRTC-22.4%COH18.1%4DX—PHIA8.4%SHL11.4%SN12.1%Median -8.6%

Net Margin

Higher is better
IRTC-3.5%COH14.6%4DX-3,684.6%PHIA5.5%SHL9.1%SN10.1%Median -5.7%

Revenue Growth

Higher is better
IRTC27.4%COH2.0%4DX-26.0%PHIA-1.9%SHL-0.3%SN—Median 7.4%

P/E

Lower is better
IRTC—LIVN43.84HAE35.64ITGR22.68TMDX15.00AXGN—Median 26.82

ROE

Higher is better
IRTC-22.4%LIVN9.5%HAE12.0%ITGR8.6%TMDX45.2%AXGN-18.0%Median -8.6%

Net Margin

Higher is better
IRTC-3.5%LIVN7.5%HAE7.3%ITGR7.7%TMDX27.0%AXGN-13.2%Median -5.7%

Revenue Growth

Higher is better
IRTC27.4%LIVN12.4%HAE-2.0%ITGR6.0%TMDX30.2%AXGN22.4%Median 7.4%

All Metrics

Valuation
MetricIRTCCOH4DXPHIASHLSNInd. Median
P/E—24.27—24.4618.72●20.7326.82
P/B25.414.32-76.08●2.082.152.502.50
EV/EBITDA339.5115.20—10.7611.949.94●15.54
P/S5.203.55249.461.35●1.702.102.69
Financial Health
MetricIRTCCOH4DXPHIASHLSNInd. Median
Current Ratio5.172.466.57●1.321.102.573.28
Debt/Equity452.4%22.1%-22.6%●71.1%84.1%62.9%44.7%
NetDebt/EBITDA14.260.42●0.712.033.041.720.82
Profitability
MetricIRTCCOH4DXPHIASHLSNInd. Median
Net Margin-3.5%14.6%●-3,684.6%5.5%9.1%10.1%-5.7%
ROE-22.4%18.1%●—8.4%11.4%12.1%-8.6%
ROA-2.9%12.4%●-264.3%3.6%4.6%6.1%-6.4%
EBITDA Margin1.6%24.0%-818.8%15.4%19.1%25.6%●5.2%
Growth + Dividend
MetricIRTCCOH4DXPHIASHLSNInd. Median
Rev. Growth27.4%●2.0%-26.0%-1.9%-0.3%—7.4%
NI Growth—-6.8%—160.1%●0.3%—16.7%
Div. Yield—3.6%●—3.5%2.9%3.5%1.1%
Payout—81.5%—33.8%48.4%52.8%39.0%
Valuation
MetricIRTCLIVNHAEITGRTMDXAXGNInd. Median
P/E—43.8435.6422.6815.00●—26.82
P/B25.413.884.351.90●5.229.692.50
EV/EBITDA339.5120.8315.8713.80●21.32—15.54
P/S5.203.282.601.74●4.059.962.69
Financial Health
MetricIRTCLIVNHAEITGRTMDXAXGNInd. Median
Current Ratio5.171.332.953.756.747.10●3.28
Debt/Equity452.4%27.6%153.8%81.4%174.8%8.4%●44.7%
NetDebt/EBITDA14.26-0.95●3.494.132.877.530.82
Profitability
MetricIRTCLIVNHAEITGRTMDXAXGNInd. Median
Net Margin-3.5%7.5%7.3%7.7%27.0%●-13.2%-5.7%
ROE-22.4%9.5%12.0%8.6%45.2%●-18.0%-8.6%
ROA-2.9%4.2%4.0%4.2%15.1%●-13.0%-6.4%
EBITDA Margin1.6%15.0%21.0%18.0%22.0%●-3.5%5.2%
Growth + Dividend
MetricIRTCLIVNHAEITGRTMDXAXGNInd. Median
Rev. Growth27.4%12.4%-2.0%6.0%30.2%●22.4%7.4%
NI Growth——-42.0%84.5%251.2%●—16.7%
Div. Yield——————1.1%
Payout——————39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IRTC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.